Learn how clinical supply teams can anticipate enrollment changes, manage inventory risks, respond to shipment delays, and make trade-offs to protect clinical trial supply.
- Can Standardizing Protocols Improve Clinical Supply Execution?
- Direct-To-Patient Trials Are Changing The Clinical Supply Chain
- When Clinical Supply Data Disagrees: Who Owns The Decision?
- The Bullwhip Effect Hits Clinical Supply Chains
- Does Clinical Development Really Need An S&OP?
- What Your Tier 1 Supplier Map Might Be Missing
- Clinical Trial Supply Chains Need To Prepare For A Less Predictable World
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Transforming The Pharma Supply Chain
Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
Logistics In Cell Therapy: Reducing Workflow Risk
Explore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Navigate Complex Ancillary Supply Sourcing Challenges
Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
Building Clinical Supply Agility In A Changing Trial Landscape
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
The Dual Sourcing Approach
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
BEYOND THE HEADLINES
What happened. What it means for clinical supply.
-
Filament Health will supply psilocybin for a proposed Belgian compassionate use program, pending regulatory approval and required authorizations for cross-border supply.
-
Prelude Therapeutics and Lilly agree to supply two medicines for a Phase 1 breast cancer trial, highlighting coordination needs as the study advances to combination cohorts.
-
Lonza expands its accelerated DNA-to-IND pathway to complex biologics, targeting IND readiness in as little as six months and raising clinical supply planning considerations.
-
FedEx launches a digital booking portal across 26 European markets for temperature-controlled pharmaceutical shipments, packaging orders, scheduling, and returns.
-
Andelyn Biosciences and PQP Group partner to coordinate import, QP certification, and distribution for cell and gene therapies entering European clinical supply markets.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.